Stay up-to-date with the latest news, articles, and industry insights from VigiLanz.
Healthcare Innovation Recognizes Jocasta Olp as Inaugural 40 Under 40 Award Winner
Award winners were chosen for their ability to advance and innovate healthcare.
AI Gives Pharmacists More Time for Patient Care
Dr. Hayley Burgess offers her thoughts on how AI can enhance the future of pharmacy workflow solutions in this new article from Drug Topics Magazine.
VigiLanz Announces Winners of 2023 Vigi Awards
Read how this year’s clinical superstars are using VigiLanz to improve outcomes and enhance patient care.
Optimize Your Hospital’s Safety Event Reporting
Your guide to the must-have elements of effective programs.
VigiLanz Announces Expansion of Leadership Team with Addition of Jamie Dailey as Senior Vice President of Growth
Meet Jamie Dailey, VigiLanz’s new Senior Vice President of Growth.
When It Comes to Patient Safety, ‘Good Enough’ Is Simply Not | PSQH
VigiLanz CEO David Goldsteen comments on the evolution of patient safety.
In Honor of Patient Safety Awareness Week: A Message from Dr. Hayley Burgess
For more than 20 years, VigiLanz has put patient safety and wellbeing at the heart of everything we do, and we remain committed to providing our pharmacists, infection preventionists, researchers, and safety professionals with the tools and the support you need to make a difference at your hospitals.
Why We Believe Patient Safety Should Be At The Heart Of Every Hospital’s Innovation Strategy
David Goldsteen, MD, former Emergency Department physician and VigiLanz’s co-founder and CEO, shares his take on some of the biggest safety improvements that have been made, as well as the steps hospitals can take to create a safer environment for all patients.
VigiLanz Ranked No. 1 by KLAS Research for Pharmacy Surveillance for Sixth Consecutive Year
This is the sixth consecutive year that VigiLanz has been recognized by KLAS as the industry leader in Pharmacy Surveillance, bringing its total count of KLAS awards to 12.
Q&A: Sharp HealthCare’s Commitment to, and Experience With, Clinical Trials
Five questions for DeAnn Cary, PhD, Director of Research at Sharp HealthCare
VigiLanz Announces Launch of New Clinical Trial Patient Identification Solution
By automating the patient identification process, VigiLanz Research will provide help for clinical trial sites seeking to accelerate patient recruitment, meet time-sensitive enrollment targets, and gain insights on patients screened for eligibility.
VigiLanz Announces Winners of 2022 Vigi Awards
Award winners recognized for optimal and innovative use of clinical surveillance to support and improve patient care